Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results
-
Published:2024-05
Issue:
Volume:46
Page:100764
-
ISSN:2405-6308
-
Container-title:Clinical and Translational Radiation Oncology
-
language:en
-
Short-container-title:Clinical and Translational Radiation Oncology
Author:
Ratosa IvicaORCID, Montero AngelORCID, Ciervide Raquel, Alvarez Beatriz, García-Aranda Mariola, Valero Jeannette, Chen-Zhao Xin, Lopez Mercedes, Zucca Daniel, Hernando Ovidio, Sánchez Emilio, de la Casa Miguel Angel, Alonso Rosa, Fernandez-Leton Pedro, Rubio Carmen
Reference37 articles.
1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Radiotherapy to regional nodes in early breast cancer: Individual-patient-data meta-analysis of 14,324 women in 16 trials. In Press. Lancet 2023;6736:1–13. doi:10.1016/S0140-6736(23)01082-6. 2. European Society for Radiotherapy and Oncology Advisory Committee in radiation oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer;Meattini;Lancet Oncol,2022 3. Curigliano G, Burstein HJ, Gnant M, Loibl S, Cameron D, Regan MM, et al. Understanding breast cancer complexity to improve patient outcomes: The St. Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023. Ann Oncol 2023;xxx. doi:10.1016/j.annonc.2023.08.017. 4. Hypofractionation: the standard for external beam breast irradiation;Brunt;Breast,2023 5. Loibl S, André F, Bachelot T, Barrios CH, Bergh J, Burstein HJ, et al. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up† Ann Oncol 2023. doi:10.1016/j.annonc.2023.11.016.
|
|